244 related articles for article (PubMed ID: 15350128)
1. Crystal structure of quinone reductase 2 in complex with resveratrol.
Buryanovskyy L; Fu Y; Boyd M; Ma Y; Hsieh TC; Wu JM; Zhang Z
Biochemistry; 2004 Sep; 43(36):11417-26. PubMed ID: 15350128
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.
St John SE; Jensen KC; Kang S; Chen Y; Calamini B; Mesecar AD; Lipton MA
Bioorg Med Chem; 2013 Oct; 21(19):6022-37. PubMed ID: 23953689
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
Sun B; Hoshino J; Jermihov K; Marler L; Pezzuto JM; Mesecar AD; Cushman M
Bioorg Med Chem; 2010 Jul; 18(14):5352-66. PubMed ID: 20558073
[TBL] [Abstract][Full Text] [Related]
4. Old and new inhibitors of quinone reductase 2.
Ferry G; Hecht S; Berger S; Moulharat N; Coge F; Guillaumet G; Leclerc V; Yous S; Delagrange P; Boutin JA
Chem Biol Interact; 2010 Jul; 186(2):103-9. PubMed ID: 20399199
[TBL] [Abstract][Full Text] [Related]
5. Insights into the redox cycle of human quinone reductase 2.
Reybier K; Perio P; Ferry G; Bouajila J; Delagrange P; Boutin JA; Nepveu F
Free Radic Res; 2011 Oct; 45(10):1184-95. PubMed ID: 21762045
[TBL] [Abstract][Full Text] [Related]
6. X-ray structural studies of quinone reductase 2 nanomolar range inhibitors.
Pegan SD; Sturdy M; Ferry G; Delagrange P; Boutin JA; Mesecar AD
Protein Sci; 2011 Jul; 20(7):1182-95. PubMed ID: 21538647
[TBL] [Abstract][Full Text] [Related]
7. Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2.
Calamini B; Santarsiero BD; Boutin JA; Mesecar AD
Biochem J; 2008 Jul; 413(1):81-91. PubMed ID: 18254726
[TBL] [Abstract][Full Text] [Related]
8. Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines.
Kwiek JJ; Haystead TA; Rudolph J
Biochemistry; 2004 Apr; 43(15):4538-47. PubMed ID: 15078100
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic mechanisms facilitated by resveratrol and its metabolites.
Calamini B; Ratia K; Malkowski MG; Cuendet M; Pezzuto JM; Santarsiero BD; Mesecar AD
Biochem J; 2010 Jul; 429(2):273-82. PubMed ID: 20450491
[TBL] [Abstract][Full Text] [Related]
10. Application of open-access databases to determine functional connectivity between resveratrol-binding protein QR2 and colorectal carcinoma.
Doonan BB; Schaafsma E; Pinto JT; Wu JM; Hsieh TC
In Vitro Cell Dev Biol Anim; 2017 Aug; 53(7):575-578. PubMed ID: 28646291
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of quinone reductase 2 by resveratrol in cultured vascular smooth muscle cells.
Cai JB; Zhang ZH; Xu DJ; Qian ZY; Wang ZR; Huang YZ; Zou JG; Cao KJ
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1419-25. PubMed ID: 18671725
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954.
Fu Y; Buryanovskyy L; Zhang Z
Biochem Biophys Res Commun; 2005 Oct; 336(1):332-8. PubMed ID: 16129418
[TBL] [Abstract][Full Text] [Related]
13. Three Australian Lepidosperma Labill. Species as sources of prenylated and oxyprenylated derivatives of piceatannol, resveratrol and pinosylvin: Melatoninergic binding and inhibition of quinone reductase 2.
Hamid K; Tran VH; Duke RK; Duke CC
Phytochemistry; 2022 Nov; 203():113396. PubMed ID: 35998831
[TBL] [Abstract][Full Text] [Related]
14. In silico and biochemical analyses identify quinone reductase 2 as a target of piceatannol.
Hsieh TC; Bennett DJ; Lee YS; Wu E; Wu JM
Curr Med Chem; 2013; 20(33):4195-202. PubMed ID: 23992305
[TBL] [Abstract][Full Text] [Related]
15. Structures of mammalian cytosolic quinone reductases.
Foster CE; Bianchet MA; Talalay P; Faig M; Amzel LM
Free Radic Biol Med; 2000 Aug; 29(3-4):241-5. PubMed ID: 11035252
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2.
Reddy PV; Jensen KC; Mesecar AD; Fanwick PE; Cushman M
J Med Chem; 2012 Jan; 55(1):367-77. PubMed ID: 22206487
[TBL] [Abstract][Full Text] [Related]
17. Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems.
Yan C; Dufour M; Siegel D; Reigan P; Gomez J; Shieh B; Moody CJ; Ross D
Biochemistry; 2011 Aug; 50(31):6678-88. PubMed ID: 21718050
[TBL] [Abstract][Full Text] [Related]
18. NRH:quinone reductase 2: an enzyme of surprises and mysteries.
Vella F; Ferry G; Delagrange P; Boutin JA
Biochem Pharmacol; 2005 Dec; 71(1-2):1-12. PubMed ID: 16253210
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2.
Hsieh TC; Lin CY; Bennett DJ; Wu E; Wu JM
PLoS One; 2014; 9(6):e101070. PubMed ID: 24968355
[TBL] [Abstract][Full Text] [Related]
20. Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells.
Hsieh TC
Asian J Androl; 2009 Nov; 11(6):653-61. PubMed ID: 19767760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
